as 11-21-2024 10:32am EST
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
Founded: | 1999 | Country: | United States |
Employees: | N/A | City: | BRENTWOOD |
Market Cap: | 405.4M | IPO Year: | N/A |
Target Price: | $13.14 | AVG Volume (30 days): | 416.3K |
Analyst Decision: | Buy | Number of Analysts: | 7 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -3.39 | EPS Growth: | N/A |
52 Week Low/High: | $5.32 - $20.11 | Next Earning Date: | 11-07-2024 |
Revenue: | $226,113,000 | Revenue Growth: | -4.33% |
Revenue Growth (this year): | 0.34% | Revenue Growth (next year): | 8.47% |
CYRX Breaking Stock News: Dive into CYRX Ticker-Specific Updates for Smart Investing
PR Newswire
9 days ago
Simply Wall St.
12 days ago
GuruFocus.com
13 days ago
MT Newswires
13 days ago
Zacks
14 days ago
PR Newswire
14 days ago
GuruFocus.com
15 days ago
Zacks
21 days ago
The information presented on this page, "CYRX CryoPort Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.